-Adrenergic regulation of human renal function

Fundamental and Clinical Pharmacology

Volumn 10, Issue 6, 1996, Pages 493-503

  Michel, M C ^a   Rump, L C ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

1 adrenoceptor; Clonidine; Glomerular filtration rate; Human kidney; Renal blood flow; 2 adrenoceptor

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CLONIDINE; DOXAZOSIN; INDORAMIN; PHENTOLAMINE; PRAZOSIN; YOHIMBINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADRENERGIC SYSTEM; ANGIOGRAPHY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; REVIEW; VASOCONSTRICTION; DRUG EFFECT; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; HUMANS; HYPERTENSION; KIDNEY; RECEPTORS, ADRENERGIC, ALPHA;

EID: 0029658714     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00606.x     Document Type: Review

References (107)

1. Allan DR, Penner SB, Smyth DD. Renal imidazoline preferring sites and solute excretion in the rat. Br J Pharmacol 1993;108:870-5
2. Bauer JH, Jones LB, Gaddy P. Effects of prazosin therapy on BP, renal function and body fluid composition. Arch Intern Med 1984;144:1196-200
3. 2-adrenergic receptor subtypes in human tissues. Anesthesiology 1994;81:1235-44
4. Berthelsen S, Pettinger WA. A functional basis for classification of alpha-adrenergic receptors. Life Sci 1977;21:595-606
5. + channels in sympathetic neurons by neuropeptides and other ganglionic transmitters. Neuron 1990;2:379-91
6. 2-adrenoceptors in rat isolated kidney: involvement of purines and prostaglandins. Naunyn Schmiedebergs Arch Pharmacol 1993a;347:273-9
7. 2-Autoreceptor subclassification in rat isolated kidney by use of short trains of electrical stimulation. Br J Pharmacol 1993b; 108:262-8
8. 2D-Adrenoceptors modulate renal noradrenaline release in normotensive and spontaneously hypertensive rats. Eur J Pharmacol 1994;271:283-92
9. Bohmann C, Rump LC, Schaible U, von Kügelgen I. α-Adrenoceptor modulation of noradrenaline and ATP release in isolated kidneys of spontaneously hypertensive rats. Hypertension 1995a;25:1224-31
10. 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats. Cardiovasc Res 1995b;30:857-65
11. Britton KE, Nawaz CC, Nimmon CC et al. Total and intrarenal flow distribution in healthy subjects: technique, acute effects of ibopamine and of indoramin. Nephron 1986;43:265-73
12. Brod J, Horbach L, Just H, Rosenthal J, Nicolescu R. Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity. Eur J Clin Pharmacol 1972;4:107-14
13. Brodde OE, Michel MC. Adrenergic receptors and their signal transduction mechanisms in hypertension. J Hypertension 1992;10(Suppl7):S133-45
14. 2-adrenoceptors is species specific. Am J Physiol 1991;261:R1242-6
15. 2-adrenoceptors in rat vas deferens. Br J Pharmacol 1993;108:336-41
16. 2-adrenergic receptors. FASEB J 1992;6:832-9
17. Bylund DB, Eikenberg DC, Hieble JP et al. IVth International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 1994;46:121-36
18. 2-Rezeptorenstimulation. Darmstadt: Steinkopff Verlag, 1983;90-8
19. de Leeuw PW, Birkenhäger WH. Alpha-adrenoceptors and the kidney. J Hypertension 1988;6(Suppl 2):S21-4
20. de Leeuw PW, De Bos R, van Es PN, Birkenhäger WH. Effect of sympathetic stimulation and intrarenal alpha-blockade on the secretion of renin by the human kidney. Eur J Clin Invest 1985;15:166-70
21. de Leeuw PW, van Es PN, De Bos R, Birkenhäger WH. Acute renal effects of doxazosin in man. Br J Clin Pharmacol 1986;21:41S-3S
22. 2-adrenergic receptors in the human hypertensive kidney. Hypertension 1987;9(Suppl III):III-210-2
23. 1-adrenoceptor. J Hypertension 1988;6 (Suppl 4):S416-7
24. 3H]RX821002 binding and definition of additional selective drugs. Eur J Pharmacol 1994;252:43-9
25. DiBona GF. Neurol control of renal function: cardiovascular implications. Hypertension 1989;13:539-48
26. 2C2 mRNA in multiple tissues. Mol Pharmacol 1993;44:70-5
27. 2-adrenoceptor agonists in collecting tubules is species dependent. Pharmacology 1992;44:26-32
28. 3H]rauwolscine? A comparison of nine tissues and cell lines. J Pharmacol Exp Ther 1995;273:1287-94
29. Ernsberger P, Feinland G, Meeley MP, Reis DJ. Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance. Am J Hypert 1990;3:90-7
30. Ernsberger P, Elliott HL, Weimann HJ et al. Moxonidine: a second-generation central antihypertensive agent. Cardiovasc Drug Rev 1993;11:411-31
31. Esler M, Dudley F, Jennings G et al. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med 1992;116:446-55
32. Firth JD, Raine AEG, Ledingham JGG. The mechanism of pressure natriuresis. J Hypertension 1990;8:97-103
33. Garg LC. Actions of adrenergic and cholinergic drugs on renal tubular cells. Pharmacol Rev 1992;44:81-102
34. 2-adrenoceptor agonist-induced diuresis. Am J Physiol 1988;255:F317-23
35. 1-adrenoceptors. Eur J Pharmacol 1995;272:R5-6
36. Golub MS, Thananopavarn C, Eggena P, Barrett JD. Hormonal and hemodynamic effects of short- and long-term clonidine therapy in patients with mild-to-moderate hypertension. Chest 1983;83(Suppl):377-9
37. Guthrie GP, Kotchen TA, van Loon GR. Effect of transdermal clonidine on the endocrine responses to insulin-induced hypoglycemia in essential hypertension. Clin Pharmacol Ther 1989;45:417-23
38. Guyton AC. Blood pressure control - special role of the kidneys and body fluids. Science 1991;252:1813-6
39. 3H]RX821002 as radioligands. Biochem Biophys Acta 1995;1266:207-14
40. Hamaya Y, Nishikawa T, Dohi S. Diuretic effect of clonidine during isoflurane, nitrous oxide, and oxygen anesthesia. Anesthesiology 1994;81:811-9
41. 1-adrenoceptors: consensus update. Pharmacol Rev 1995;47:267-70
42. 1C-adrenergic receptor. Biochem Biophys Res Commun 1993;195:902-9
43. Izzo JL, Horwitz D, Keiser HR. Physiological mechanisms opposing the hemodynamic effects of prazosin. Clin Pharmacol Ther 1981;29:7-11
44. 1-adrenergic receptor response coupling in spontaneously hypertensive rats. Hypertension 1988;12:80-8
45. Keeton TK, Campbell WB. The pharmacological alteration of renin release. Pharmacol Rev 1981;32:81-227
46. 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors. Mol Pharmacol 1991;39:407-13
47. Kline RL, Cechetto DF. Renal effects of rilmenidine in anesthetized rats: importance of renal nerves. J Pharmacol Exp Ther 1993;266:1556-62
48. Kobrin I, Messerli FH, Amodeo C, Ventura HO, Frohlich ED. Immediate hemodynamic effect of urapidil in patients with essential hypertension. Am J Cardiol 1985;55:722-5
49. 2-adrenergic binding sites in basolateral membranes from human kidney. Eur J Pharmacol 1991;206:23-31
50. 2-Adrenoceptors activate dihydropyridine-sensitive calcium channels via Gi-proteins and protein kinase C in rat portal vein myocytes. Pflugers Arch 1994;429:253-61
51. Li P, Smyth DD. Suppressed renal response to 2,6-dimethyl clonidine but not clonicine in one kidney-one clip hypertensive rats. J Pharmacol Exp Ther 1993;267:1395-400
52. Limbird LE. Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. FASEB J 1988;2:2686-95
53. Ludwig H. Influence of long-term therapy with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride on renal haemodynamics in arterial hypertension. Arzneimittelforsch/Drug Res 1968;18:600-4
54. Mayorov D, Chernobelski M, Medvedev O. Sympathoinhibitory action of rilmenidine in conscious sinoaortically denervated rats. J Cardiovasc Pharmacol 1993;22:314-20
55. Meister B, Dagerlind A, Nicholas AP, Hökfelt T. Patterns of messenger RNA expression for adrenergic receptor subtypes in rat kidney. J Pharmacol Exp Ther 1994;268:1605-11
56. Meurer KA, Kloos G, Helber A, Kaufmann W. Über die Beeinflussung der Reninfreisetzung durch Clonidin. Klin Wochenschr 1976;54:261-5
57. Michel MC, Insel PA. How many imidazoline-preferring binding sites are there? Trends Pharmacol Sci 1989;10:342-4
58. 2+ in human erythroleukemia cells. J Biol Chem 1989a;264:4986-91
59. 2-adrenergic drugs also bind with high affinity to a non-adrenergic site. Mol Pharmacol 1989b;35:324-30
60. Michel MC, Insel PA, Brodde OE. Renal α-adrenergic receptor alterations: a cause of essential hypertension? FASEB J 1989c;3:139-44
61. 2-adrenergic receptors. Mol Pharmacol 1990;37:65-8
62. Michel MC, Jäger S, Casto R et al. On the role of renal α-adrenergic receptors in spontaneously hypertensive rats. Hypertension 1992a;19:365-70
63. Michel MC, Philipp T, Brodde OE. α- and β-adrenoceptors in hypertension: molecular biology and pharmacological studies. Pharmacol Toxicol 1992b;70(Suppl II):S1-10
64. 2-adrenoceptor subtypes. Mol Pharmacol 1993a;44: 1165-70
65. 2- and β-adrenergic receptors and their signaling. Hypertension 1993b;22:169-77
66. Michel MC, Farke W, Erdbrügger W, Philipp T, Brodde OE. Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. II. Renal G proteins in male and female rats. Hypertension 1994;23:653-8
67. 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 1995;352:1-10
68. 2-adrenoceptors in the human kidney. Clin Exp Pharmacol Physiol 1993;20:523-6
69. 2+. Pharmacol Rev 1988;40: 87-119
70. 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. Mol Pharmacol 1988;33:509-14
71. 2-adrenoceptors in human myometrium and kidney: similarities with human platelets, but differences to rat kidney. J Hypertension 1989;7(Suppl 6):S50-1
72. 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species. Br J Pharmacol 1985;85:349-59
73. 3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther 1994;268:1362-7
74. Onesti G, Schwarz AB, Kim KE, Swartz C, Brest AN. Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155). Circulation 1969;39:219-28
75. Penner SB, Stanko CK, Smyth DD. Selective alpha-1 adrenoceptor blockade and renal sodium handling in humans. J Clin Pharmacol 1993;33:1110-5
76. 2-adrenergic receptor subtype mRNAs in human tissues. Mol Brain Res 1992;16:57-63
77. 1D-adrenergic receptors to multiple signaling pathways is both G protein and cell type specific. Mol Pharmacol 1993;44:784-95
78. Petersen JS, DiBona GF. Reflex control of renal sympathetic nerve activity during furosemide diuresis in rats. Am J Physiol 1994;266:R537-45
79. 2-adrenoceptors and the adenylate cyclase-cAMP system: biochemical and physiological interactions. Am J Physiol 1987;252:F199-208
80. ++ channels. J Pharmacol Exp Ther 1994;270:788-94
81. Preston RA, O'Connor DT, Stone RA. Prazosin and renal hemodynamics: arteriolar vasodilation during therapy of essential hypertension in man. J Cardiovasc Pharmacol 1979;1:277-86
82. 1-adrenergic receptor subtypes in human tissues: implications for human a-adrenergic physiology. Mol Pharmacol 1994;45:171-5
83. Propping P, Friedl W. Genetic control of adrenergic receptors on human platelets. Hum Genet 1983;64:105-9
84. 1B-adrenergic receptor. J Biol Chem 1992;267:21936-45
85. Reis DJ, Ernsberger P, Meeley MP. Imidazole receptors and their endogenous ligand in the rostral ventrolateral medulla: relationship to the action of clonidine on arterial pressure. In: Ciriello J, Kunos G, eds. Central Neural Mechanisms in Cardiovascular Regulation. New York: Birkhauser Boston, 1991;55-68
86. Roulot D, Moreau R, Gaudin C et al. Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites. Gastroenterology 1992;102:1309-18
87. Ruffolo RR Jr, Hieble JP. α-Adrenoceptors. Pharmacol Ther 1994;61:1-64
88. Rump LC. Modulation of renal noradrenaline release by prejunctional receptor systems in vitro. Clin Exp Pharmacol Physiol 1987;14:423-8
89. 2-adrenoceptors in rat isolated kidneys. J Cardiovasc Pharmacol 1987;9:500-7
90. Rump LC, Schollmeyer P. Modulation der renalen Transmitter-Freisetzung durch präsynaptische Rezeptoren. Klin Wochenschr 1989;67:865-9
91. 2-Adrenoceptor activation inhibits noradrenaline release in human and rabbit isolated arteries. Eur J Pharmacol 1991;196: 277-83
92. 2-receptor activation inhibits noradrenaline release in human kidney slices. Kidney Int 1993;43:197-204
93. Sano N, Way D, McGrath BP. Renal norepinephrine spillover and baroreflex responses in evolving heart failure. Am J Physiol 1990;258:F1516-22
94. Schwinn DA, Johnston GL, Page SO et al. Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species. J Pharmacol Exp Ther 1995;272:134-42
95. 2-adrenergic receptor gene. Cell Regul 1990;1:445-51
96. 1B-adrenoceptors. Eur J Pharmacol 1993;238:407-10
97. 2-adrenoceptors in the anesthetized rat. FASEB J 1991;5:A502
98. Stanaszek WF, Kellerman D, Brogden RN, Romankiewicz JA. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs 1983;25:339-84
99. 3H]prazosin in rat, dog and human kidney. J Auton Pharmacol 1986;6:109-16
100. Tesson F, Prip-Buus C, Lemoine A, Pegorier JP, Parini A. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. J Biol Chem 1991;266:155-60
101. 2-imidazoline binding sites on monoamine oxidase. J Biol Chem 1995;270:9856-61
102. Todesco S, Huber W, Romagnoli GF, Gambari PF, Guardini R, Borsatti A. Effects of clonidine therapy on exchangeable sodium and renal hemodynamics in essential hypertension. Arzneimittelforsch/Drug Res 1974;24:348-51
103. 2C-subtype mediate inhibition of norepinephrine release in human kidney cortex. Mol Pharmacol 1994;45:1168-76
104. 2-adrenoceptors in the human kidney: radio-ligand binding study in membranes from the human renal cortex and medulla. J Hypertension 1986;4(Suppl 6):S222-5
105. 1C. Biochem Biophys Res Commun 1994;201: 1296-304
106. 1 inhibition on renal blood flow and sympathetic nervous activity in systemic hypertension. Am J Cardiol 1987;59:62G-86G
107. 2-adrenoceptor-mediated renal vasoconstriction in conscious rats. Am J Physiol 1989;257:F1132-9